Compare EHC & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EHC | ELAN |
|---|---|---|
| Founded | 1983 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 12.7B |
| IPO Year | 1994 | 2018 |
| Metric | EHC | ELAN |
|---|---|---|
| Price | $106.49 | $23.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $143.29 | $27.89 |
| AVG Volume (30 Days) | 866.9K | ★ 4.3M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | ★ 24.22 | N/A |
| EPS | ★ 5.54 | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $9.33 | $8.21 |
| Revenue Next Year | $8.14 | $5.31 |
| P/E Ratio | $19.20 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $92.77 | $8.59 |
| 52 Week High | $127.99 | $27.72 |
| Indicator | EHC | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 59.58 | 48.86 |
| Support Level | $105.88 | $22.17 |
| Resistance Level | $109.21 | $23.70 |
| Average True Range (ATR) | 2.44 | 0.90 |
| MACD | 0.55 | 0.05 |
| Stochastic Oscillator | 81.03 | 63.87 |
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.